Teacher Retirement System of Texas bought a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the first quarter, Holdings Channel reports. The institutional investor bought 72,085 shares of the medical instruments supplier’s stock, valued at approximately $4,501,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XRAY. Flinton Capital Management LLC purchased a new position in DENTSPLY SIRONA during the fourth quarter worth approximately $671,000. Renaissance Technologies LLC increased its position in DENTSPLY SIRONA by 67.3% in the fourth quarter. Renaissance Technologies LLC now owns 301,858 shares of the medical instruments supplier’s stock worth $17,426,000 after buying an additional 121,400 shares in the last quarter. Allianz Asset Management AG increased its position in DENTSPLY SIRONA by 76.4% in the fourth quarter. Allianz Asset Management AG now owns 337,122 shares of the medical instruments supplier’s stock worth $19,462,000 after buying an additional 146,005 shares in the last quarter. Credit Agricole S A increased its position in DENTSPLY SIRONA by 17.6% in the fourth quarter. Credit Agricole S A now owns 159,722 shares of the medical instruments supplier’s stock worth $9,221,000 after buying an additional 23,890 shares in the last quarter. Finally, Elkfork Partners LLC purchased a new position in DENTSPLY SIRONA during the fourth quarter worth approximately $1,425,000. 95.29% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Shares of DENTSPLY SIRONA Inc. (XRAY) traded up 0.62% during mid-day trading on Friday, hitting $63.70. The company had a trading volume of 1,700,481 shares. The firm’s 50 day moving average is $63.20 and its 200-day moving average is $61.05. DENTSPLY SIRONA Inc. has a 12-month low of $55.00 and a 12-month high of $65.68. The firm has a market cap of $14.60 billion, a PE ratio of 40.99 and a beta of 1.25.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Tuesday, May 9th. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by $0.01. The company had revenue of $900.50 million for the quarter, compared to analyst estimates of $916.55 million. DENTSPLY SIRONA had a net margin of 9.42% and a return on equity of 7.37%. The firm’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.69 earnings per share. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post $2.84 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.watchlistnews.com/teacher-retirement-system-of-texas-buys-new-stake-in-dentsply-sirona-inc-xray/1372585.html.

A number of research analysts have commented on the company. BidaskClub downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, June 10th. Zacks Investment Research raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating and set a $71.00 target price on the stock in a report on Tuesday, May 2nd. Barrington Research downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Tuesday, February 21st. Cleveland Research raised DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. Finally, Goldman Sachs Group, Inc. (The) downgraded DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and reduced their target price for the stock from $60.00 to $55.00 in a report on Tuesday, May 23rd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and eight have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $66.44.

In other DENTSPLY SIRONA news, CEO Christopher T. Clark sold 89,700 shares of DENTSPLY SIRONA stock in a transaction that occurred on Friday, April 7th. The stock was sold at an average price of $62.67, for a total transaction of $5,621,499.00. Following the sale, the chief executive officer now directly owns 112,067 shares of the company’s stock, valued at $7,023,238.89. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO James G. Mosch sold 50,600 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, April 24th. The shares were sold at an average price of $63.49, for a total value of $3,212,594.00. Following the sale, the chief executive officer now directly owns 105,083 shares in the company, valued at $6,671,719.67. The disclosure for this sale can be found here. 1.99% of the stock is currently owned by insiders.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.